News — Founders


EMBAs from MIT Sloan boosting CLCC’s US strategy

We’re delighted to welcome Jaren, Humaira and TJ to our offices – three dynamic Executive MBAs from MIT Sloan School of Management who are working closely with Lara, myself and the rest of our Calla Lily Clinical Care leadership team over the next 4 months. As part of MIT Sloan’s Global Organizations action learning lab …

Panel at M&G Investments: The Role of Innovation in Closing the Gender Healthcare Gap

We’re looking forward to hearing perspectives from an esteemed panel of experts (including our co-founder Lara Zibners) on the role of innovation in Closing the Gender Healthcare Gap, hosted by THENA Capital in collaboration with M&G Investments. Lara will be sharing the stage with Professor Dame Lesley Regan – Women’s Health Ambassador for England and …

Beyond Infertility: Progesterone for Menopause, PCOS, and Endometriosis
Lara Zibners MD MMEd MBA
Co-Founder & Chairman

When you hear the word “progesterone”, the hormone’s role in fertility treatments may be the first thing that comes to mind. After all, it’s “pro” “gest.” Get it? However, progesterone is not just for women trying to conceive—it also has a critical role in the management of other conditions that affect women throughout their lives. …

R&D team excellence
Thang Vo-Ta
CEO & Co-Founder

A shout-out to our incredible Calla Lily Clinical Care Team. With some key deadlines approaching, our R&D team has been working with relentless dedication, precision, and an unwavering commitment to excellence.💥 This is where the real ✨magic happens at our firm – brilliant minds, working hard, driven by purpose, coming together to push the boundaries …

200 Trailblazing Leaders in Women’s Health & FemTech

Our co-founders Lara and Thang have been named in the annual ‘200 Trailblazing Leaders in Women’s Health and FemTech’ for the second year running.  It’s a real who’s who of the influential leaders working to improve the access and quality of healthcare for women worldwide.  We’re delighted at the recognition for Lara & Thang and …

Femmehealth Ventures Podcast episode with Lara

🔊 Our co-founder, Dr Lara Zibners shares candid insights in a compelling podcast interview with Femmehealth Ventures. If you’ve ever thought, “There has to be a better way,” when it comes to drug delivery for women’s health, this episode is a must-listen. Lara shares her personal journey through IVF, the challenges of existing solutions, and …

5 things I learned at JPM
Lara Zibners MD MMEd MBA
Co-Founder & Chairman

I am still feeling the jet lag but back in the swing of things and have finally had some time to reflect on the whirlwind that was JPM Week in San Francisco. 1.        You don’t have to be one of the “cool kids.” In high school, I always felt like I was just on the …

Panel at Zinc VC: Candid Insights on Building Healthcare Startups
Thang Vo-Ta
CEO & Co-Founder

Back in London and straight onto a panel at Zinc VC, sharing insights on building healthcare businesses as part of Zinc’s venture builder bootcamp. It’s always a pleasure to connect with a room full of ambitious, mission driven new founders.  Perhaps part cathartic (part therapeutic?) – but I do enjoy being very candid in such …

Why Intravaginal Progesterone Therapy is a Smart Choice and a Smart Investment
Lara Zibners MD MMEd MBA
Co-Founder & Chairman

Progesterone therapy is a crucial part of women’s reproductive health, particularly in fertility treatments, endometriosis management, and menstrual regulation. I took it when I was trying to get pregnant and I took it when I was trying to stop bleeding through my clothes (thanks fibroids!) and I took it as part of my journey through …

End of Year Reflection
Thang Vo-Ta
Co-Founder & CEO

As we wrap up the year, Lara and I couldn’t be prouder of our team and everything we’ve accomplished together. While we hope most of our milestones have been celebrated here on LinkedIn, I have to emphasise that behind these happy faces at our year-end festivities are some of the most hard-working and resilient colleagues …